Literature DB >> 18298273

Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications.

Bruce D Homer1, Todd M Solomon, Robert W Moeller, Amy Mascia, Lauren DeRaleau, Perry N Halkitis.   

Abstract

The highly addictive drug methamphetamine has been associated with impairments in social cognitions as evidenced by changes in users' behaviors. Physiological changes in brain structure and functioning, particularly in the frontal lobe, have also been identified. The authors propose a biopsychosocial approach to understanding the effects of methamphetamine addiction by relating the physiological effects of the drug to the behaviors and social cognitions of its users, through the application of the theory of mind paradigm. Although onset of methamphetamine use has been linked to the desire for socialization, chronic use has been associated with an increase in depression, aggressiveness, and social isolation, behaviors that also implicate involvement of the frontal lobe. The reviewed literature provides strong circumstantial evidence that social-cognitive functioning is significantly impacted by methamphetamine use and that the social isolation, depression, and aggressiveness associated with chronic use is due to more than just the social withdrawal associated with addiction. Treatment considerations for methamphetamine must therefore consider the role of social cognition, and pharmacological responses must address the documented impact of the drug on frontal lobe functioning. (c) 2008 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298273     DOI: 10.1037/0033-2909.134.2.301

Source DB:  PubMed          Journal:  Psychol Bull        ISSN: 0033-2909            Impact factor:   17.737


  70 in total

1.  The environment and schizophrenia.

Authors:  Jim van Os; Gunter Kenis; Bart P F Rutten
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  Neural correlates of affect processing and aggression in methamphetamine dependence.

Authors:  Doris E Payer; Matthew D Lieberman; Edythe D London
Journal:  Arch Gen Psychiatry       Date:  2010-11-01

3.  Violence perpetrated by women who use methamphetamine.

Authors:  Alison B Hamilton; Nicholas E Goeders
Journal:  J Subst Use       Date:  2010-10

4.  Causes and Consequences of Drug Abuse: A Comparison Between Synthetic Drug and Heroin Users in Urban China.

Authors:  Xiushi Yang; Guomei Xia
Journal:  AIDS Educ Prev       Date:  2019-02

5.  Effective connectivity predicts cognitive empathy in cocaine addiction: a spectral dynamic causal modeling study.

Authors:  Luqing Wei; Guo-Rong Wu; Minghua Bi; Chris Baeken
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

6.  Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.

Authors:  M Galizio; P McKinney; D T Cerutti; R C Pitts
Journal:  Pharmacol Biochem Behav       Date:  2009-09-19       Impact factor: 3.533

7.  Driving on ice: impaired driving skills in current methamphetamine users.

Authors:  David Bosanquet; Hamish G Macdougall; Stephen J Rogers; Graham A Starmer; Rebecca McKetin; Alexander Blaszczynski; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2012-07-29       Impact factor: 4.530

Review 8.  Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Authors:  Matthew Brensilver; Keith G Heinzerling; Steven Shoptaw
Journal:  Drug Alcohol Rev       Date:  2013-04-25

Review 9.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

10.  Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.

Authors:  Irina N Krasnova; Zuzana Justinova; Bruce Ladenheim; Subramaniam Jayanthi; Michael T McCoy; Chanel Barnes; John E Warner; Steven R Goldberg; Jean Lud Cadet
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.